Seeking AlphaTue, 21 Apr 2026 19:51:32 GMTCybin: Regulatory Tailwinds Unlock Asymmetric Upside (Rating Upgrade)HELP-0.56%
Seeking AlphaFri, 06 Mar 2026 15:15:58 GMTCybin Inc. (HELP) Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder Prepared Remarks TranscriptHELP-0.56%
BenzingaThu, 05 Mar 2026 15:38:09 GMTHelus Pharma Stock Tumbles As Anxiety Drug Study DisappointsHELP-0.56%
Seeking AlphaWed, 25 Feb 2026 04:55:05 GMTHELUS Pharma: Transitioning From Psychedelic Research To Late-Stage Clinical NeuroscienceHELP-0.56%
